In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|2|258-265

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.2, 2018-02, pp. : 258-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1455-1458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 2, 2018-02 ,pp. : 205-208

John Wiley & Sons Inc

Access to resources Recommend Favorite

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 696-706

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population‐based programs for increasing colorectal cancer screening in the United States

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 6, 2015-11 ,pp. : 496-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 1, 2014-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite